首页> 外文期刊>Microbiology >Mechanism of conjugated linoleic acid and vaccenic acid formation in human faecal suspensions and pure cultures of intestinal bacteria
【24h】

Mechanism of conjugated linoleic acid and vaccenic acid formation in human faecal suspensions and pure cultures of intestinal bacteria

机译:缀合的亚油酸和疫苗酸形成在人粪悬浮液中的纯培养物和肠细菌纯培养

获取原文
           

摘要

Faecal bacteria from four human donors and six species of human intestinal bacteria known to metabolize linoleic acid (LA) were incubated with LA in deuterium oxide-enriched medium to investigate the mechanisms of conjugated linoleic acid (CLA) and vaccenic acid (VA) formation. The main CLA products in faecal suspensions, rumenic acid (cis-9,trans-11-CLA; RA) and trans-9,trans-11-CLA, were labelled at C-13, as were other 9,11 geometric isomers. Traces of trans-10,cis-12-CLA formed were labelled to a much lower extent. In pure culture, Bifidobacterium breve NCFB 2258 formed labelled RA and trans-9,trans-11-CLA, while Butyrivibrio fibrisolvens 16.4, Roseburia hominis A2-183T, Roseburia inulinivorans A2-192T and Ruminococcus obeum-like strain A2-162 converted LA to VA, labelled in a manner indicating that VA was formed via C-13-labelled RA. Propionibacterium freudenreichii subsp. shermanii DSM 4902T, a possible probiotic, formed mainly RA with smaller amounts of trans-10,cis-12-CLA and trans-9,trans-11-CLA, labelled the same as in the mixed microbiota. Ricinoleic acid (12-OH-cis-9-18?:?1) did not form CLA in the mixed microbiota, in contrast to CLA formation described for Lactobacillus plantarum. These results were similar to those reported for the mixed microbiota of the rumen. Thus, although the bacterial genera and species responsible for biohydrogenation in the rumen and the human intestine differ, and a second route of RA formation via a 10-OH-18?:?1 is present in the intestine, the overall labelling patterns of different CLA isomers formation are common to both gut ecosystems. A hydrogen-abstraction enzymic mechanism is proposed that may explain the role of a 10-OH-18?:?1 intermediate in 9,11-CLA formation in pure and mixed cultures.
机译:来自四种人类供体和六种已知的六种人类肠道细菌的粪便细菌与氧化氘介质中的La温育氧化氧化物培养基中的培养基,研究缀合的亚油酸(CLA)和疫苗酸(VA)的形成机制。在粪便悬浮液中,瘤酸(CIS-9,Trans-11-Cla; Ra)和Trans-11 -Cla的主要CLA产品在C-13上标记,如其他9,11个几何异构体。将形成的Racter-10迹线标记为更低的程度。在纯培养中,Bifidobacterium Breve NCFB 2258形成标记的RA和Trans-9,Trans-11-Cla,而抑制纤维糊糊剂16.4,Rosebura Hominis A2-183T,Roseburia inulinivorans A2-192T和喇叭花膜状菌株A2-162转换为VA以指示VA通过C-13标记的Ra形成Va的方式标记。 Probimibacterium Freudenreichii子公司。 Shermanii DSM 4902T,一种可能的益生菌,主要形成Ra,其具有较少量的反式-10,CIS-12-CLA和Trans-9,Trans-11-Cla,标记与混合微生物酵母相同。蓖麻油酸(12-OH-CIS-9-18?:1)在混合微生物酵母中未形成CLA,与乳酸杆菌描述的CLA形成相反。这些结果与瘤胃混合微生物群的结果类似。因此,尽管瘤胃和人肠中负责生物中的细菌属和物种不同,但是通过10-OH-18的第二次RA形成的RA形成:1在肠中存在,整体标记图案不同CLA异构体形成对肠道生态系统都是常见的。提出了一种可以解释10 -OH-18的作用的氢萃取酶机理?:纯和混合培养物中的9,11-CLA中间体中中间体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号